Concepedia

Reed W. Smith

RW

Statistics

Publications

6

Citations

157

H-Index

6

Active since

1996

Affiliations

AstraZeneca (United States)(Current)

Wilmington University

AstraZeneca (Sweden)

Reed W. Smith is an author at AstraZeneca (United States) specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

1996–2021

6

Publications

6

Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma

Matthew W. D. Perry, Karin Björhall, Peter Bold et al. · Journal of Medicinal Chemistry · 2021 · 34 citations · Full text

4-Aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators

Hui Xiong, Todd A. Brugel, Michael Balestra et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

, , +9

Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1

Todd A. Brugel, Reed W. Smith, Michael Balestra et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

, , +8

<i>N</i>-Aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides:  K<sub>ATP</sub> Potassium Channel Openers. Modifications on the Western Region

Cyrus J. Ohnmacht, Keith C. Russell, James R. Empfield et al. · Journal of Medicinal Chemistry · 1996 · 26 citations

Design and Synthesis of Soluble and Cell-Permeable PI3Kδ Inhibitors for Long-Acting Inhaled Administration

Matthew W. D. Perry, Karin Björhall, Britta Bonn et al. · Journal of Medicinal Chemistry · 2017 · 25 citations · Full text

1–5 of 6